Business
CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the first quarter ended March 31, 2026, before the market opens on Thursday, May 14, 2026, and will host a corporate update conference call at 8:30am Eastern Time. Thursday, May 14th @ 8:30am ETDomestic:1-844-676-2922International:1-412-634-6840Webcast:Webcast Link About CorMedixCorMedix Therapeutics is a biopharmaceutical company focused on develo
About this update from Cormedix Inc.
[{"type":"image","alt":"CorMedix, Inc.","displaySize":"","headline":null,"caption":"CorMedix, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":151,"url":"https://media.zenfs.com/en/globenewswire.com/04a828931a8de73e15b3cb965f763d93"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/65lhTscIye_5Abg0t_E8Pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMQ--/https://media.zenfs.com/en/globenewswire.com/04a828931a8de73e15b3cb965f763d93","width":300,"height":151}},"lazy":false},{"type":"text","content":"PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the first quarter ended March 31, 2026, before the market opens on Thursday, May 14, 2026, and will host a corporate update conference call at 8:30am Eastern Time.","length":313,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"2","style":"vertical-align:top;","val":[{"type":"text","content":"Thursday, May 14th @ 8:30am ET","length":30,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"max-width:30%;width:30%;min-width:30%;vertical-align:top;","val":[{"type":"text","content":"Domestic:","length":9,"tagName":"p","attribs":{}}]},{"style":"max-width:70%;width:70%;min-width:70%;vertical-align:top;","val":[{"type":"text","content":"1-844-676-2922","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"International:","length":14,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"1-412-634-6840","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast:","length":8,"tagName":"p","attribs":{}}]},{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast Link","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]}],"length":102},{"type":"text","content":"About CorMedixCorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institution...